Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $6.51 | Change: $-0.54 | %Change: -7.66%
Volume: 82,149 | Day High/Low: 7.05/6.50 | 52 Week High/Low: 8.33/1.66
View modes: 
3 stars

52 Week High Today

Eom  rate and reply
2 stars

P2 Valuation in Rest Of World

P2 is approved in the US only. Nuvo recently generated about $60 million ( cad ) in upfront cash , providing Horizon the right to market the drug in the US. Recently, Nuvo announced plans to...read more
2.5 stars

RE:RE:RE:Class Action by Long Term Shareholders?

Perhaps a few facts on this matter will put the history here in perpective. Former ( and corrupt ) management of Diemthaid ( now Nuvo ) brought the share price down from $13 in 2000 to pennies by...read more
4 stars

RE:RE:RE:Valuation...

Final phase 2 trials for WF10 are now underway. Nuvo will receive its headline results early in Q1/15. Most recall Cannacord's discounted NPV for Circassia allergy productions. Even though these are...read more
3.5 stars

RE:RE:Class Action by Long Term Shareholders?

This stock was bankrupt when taken over by Magna former execs. Just to be clear exactly how did these marvels of Magna come up with the money to save the company? They issued stock directly and...read more
2.5 stars

RE:RE:Valuation...

It would definitely be easier too get a vote from a competing company that made an attempt to buy-out / take-over Nuvo with the amount of disgruntled shareholders that still have shares here, however...read more
3 stars

RE:Valuation...

I agree although really what is the best real hard asset NRI has is Pennsaid 2% worldwide (ex USA).  With the move to go through phase 3 in Europe if Pennsaid gets over the counter approval by end of...read more
3.5 stars

RE:RE:Valuation...

I think that coveage is just like what you said, as being "very close". I also believe now that  we have established a solid amount of volume above the 5 dollar level and the stock set a new 52 week...read more
3 stars

RE:Valuation...

Circassia has 190 million shares and about $250 million in cash and no revenues. It is burning through cash at about the rate of $75 million per year. Big difference is coverage by 5 analysts, and...read more
5 stars

Valuation...

If Circassia with one Phase III testing product and several similar products in early testing phases, has a market cap of just under 1B CDN, then what is a realistic valuation for Nuvo 1) today?, 2...read more
2 stars

P 2 partner in Europe

Pennsaid 2% has been licensed to Paladin Labs Inc. for Canada, South Africa, Israel and Central and South America and to NovaMedica LLC for Russia and some of the Community of Independent States. The...read more
2 stars

RE:Class Action by Long Term Shareholders?

Another of the lii folk  existing in dream land of 15 years ago. This stock was bankrupt when taken over by Magna former execs. They have done a great job considering the Great Recession of 2008-9...read more
4 stars

Class Action by Long Term Shareholders?

Class Action by Long Term Shareholders? Holders of shares Higher than .20cents pre/split got the royal makeover by the so called P partner. That partner settled with the company to the tune of some...read more
3 stars

RE:RE:RE:Intermediate Target

Hey Bigwig , Now that we finally have lift off(from the basement cellar) can you and Rock make an effort to ensure that management at Nuvo doesn't do anything stupid (like hiring a consulting group...read more
3 stars

RE:RE:Intermediate Target

Actually, there arnt many canadian pharmaceuticals left on the TSX. Most have been taken over by the Seniors. The few that are left like TKM and CXR are trading on Nasdaq. They are very expensive in...read more
3 stars

RE:Intermediate Target

That doesnt make much sense. Its worth that in cash. It just goes to show how oblivious TA is to changes in fundamentals.  rate and reply
4 stars

Intermediate Target

WebBroker has a new intermediate price target for Nuvo of $6.50 to $6.80 based on the chart upside breakout.  rate and reply
5 stars

RE:RE:new 52 week high

Like I said, New 52 week high reached today, just as I thought. Watch for this to continue easily to 6 dollars and higher next week. So much interest building daily, as I saw Laurention buying heavily...read more
2.5 stars

RE:new 52 week high

nice....congrats all, playing for fun, a few shares when she hit sticker bids this past week or last week.  :) cheers, dave.  rate and reply
0 stars

RE:The Nasdaq Effect

has NRI applied for a Nasdaq listing?  rate and reply